Same Indication

Pembrolizumab vs Valsartan

## Pembrolizumab vs Valsartan: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Valsartan**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Valsartan**: Angiotensin II type 1 receptor blocker.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Valsartan — 6 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Valsartan — C24H29N5O3.

**Molecular Weight**: Pembrolizumab — N/A; Valsartan — 435.5190 g/mol.

**Type**: Pembrolizumab — Antibody; Valsartan — Small molecule.